HTA63 Building the Bridge to Access: Leveraging RWE From Early Access Schemes to Reimbursement in Gene and Cell Therapies
Dec 1, 2025, 00:00
10.1016/j.jval.2025.09.1848
https://www.valueinhealthjournal.com/article/S1098-3015(25)04405-5/fulltext
Title :
HTA63 Building the Bridge to Access: Leveraging RWE From Early Access Schemes to Reimbursement in Gene and Cell Therapies
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(25)04405-5&doi=10.1016/j.jval.2025.09.1848
First page :
Section Title :
Open access? :
No
Section Order :
11391